Transition Metal Catalysis for Pharmaceutical Intermediates and APIs

Rohner AG, a medium-sized Swiss company, has moved from toll manufacturing of building blocks and starting materials to the custom manufacturing of intermediates and APIs for the life science industry. Therefore, Rohner AG has expanded its technology portfolio to new technologies such as t...

Full description

Bibliographic Details
Main Authors: Adriano F. Indolese, Domenic Wasescha, Thomas Eisele, Christoph Bucher
Format: Article
Language:deu
Published: Swiss Chemical Society 2005-01-01
Series:CHIMIA
Subjects:
Online Access:https://chimia.ch/chimia/article/view/3937